Long-term outcomes of ThuLEP reported for benign prostatic enlargement

Long-term outcomes of ThuLEP reported for benign prostatic enlargement

The 12-year experience with thulium laser enucleation of the prostate (ThuLEP) for benign prostatic enlargement (BPE) at one tertiary referral center shows low rates of repeat treatment for recurrence or other complications, according to a study recently published in European Urology Focus.

Britta Grüne, from University Medical Center Mannheim in Germany, and colleagues examined the long-term efficacy and morbidity of ThuLEP among 1,097 patients who underwent ThuLEP at a German tertiary referral center between 2009 and 2021. Patients were retrospectively followed for reinterventions for persistence or regrowth of prostate adenoma (ReIP) or (ReIC).

The median overall follow-up was 6.0 years, and for 369 patients, median follow-up of 10 years was available. The researchers found that 42 (3.8 percent) underwent ReIP after a median of two years. The rate of long-term ReIC was 2.6 percent, with 0.5 years median time to ReIC. Urethrotomy was the most frequent ReIC (1.5 percent). At 10 years, the cumulative incidence of ReIP and ReIC was estimated at 5.6 and 3.4 percent, respectively. A significant predictor of ReIP was enucleation weight ≥60 g (hazard ratio, 1.2).

"This study hints at the first evidence indicating the durability and safety of ThuLEP for surgical treatment of BPE," the authors write. "Within a period of 12 years, ReIP and ReIC rates were low and predominantly occurred within the first five years."

More information: Britta Grüne et al, Long-term Reinterventions after Thulium Laser Enucleation of the Prostate: 12-Year Experience with more than 1000 Patients, European Urology Focus (2022). DOI: 10.1016/j.euf.2021.12.006

Copyright © 2022 HealthDay. All rights reserved.

Citation: Long-term outcomes of ThuLEP reported for benign prostatic enlargement (2022, August 31) retrieved 3 December 2022 from https://medicalxpress.com/news/2022-08-long-term-outcomes-thulep-benign-prostatic.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Few aortic dissection survivors receive long-term imaging surveillance

3 shares

Feedback to editors